Patents by Inventor John Panagides

John Panagides has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF BIPOLAR DISORDERS AND ASSOCIATED SYMPTOMS
    Publication number: 20090176855
    Abstract: The present invention relates to a method and kits for treating bipolar disorder in a mammal, including a human, the treatments including treatment of bipolar disorder including rapid-cycling, treatment of symptoms of bipolar disorder including acute mania or hypomania and depression, and episodes or occurrences including both acute mania or hypomania and depression; treatment for effecting mood stabilization; treatment for preventing relapse into bipolar episodes, and for the treatment of suicidal thoughts and tendencies associated with bipolar disorder, comprising administering to said mammal an effective amount of a compound of Formula or a pharmaceutically acceptable salt, solvate, hydrate or optical isomer thereof.
    Type: Application
    Filed: March 17, 2009
    Publication date: July 9, 2009
    Inventors: Erik Ho Fong Wong, John Panagides, Jacques Schipper
  • Treatment of bipolar disorders and associated symptoms
    Publication number: 20060084692
    Abstract: The present invention relates to a method and kits for treating bipolar disorder in a mammal, including a human, the treatments including treatment of bipolar disorder including rapid-cycling, treatment of symptoms of bipolar disorder including acute mania or hypomania and depression, and episodes or occurrences including both acute mania or hypomania and depression; treatment for effecting mood stabilization; treatment for preventing relapse into bipolar episodes, and for the treatment of suicidal thoughts and tendencies associated with bipolar disorder, comprising administering to said mammal an effective amount of a compound of Formula or a pharmaceutically acceptable salt, solvate, hydrate or optical isomer thereof.
    Type: Application
    Filed: October 11, 2005
    Publication date: April 20, 2006
    Applicants: Pfizer Inc., Organon Ireland Ltd.
    Inventors: Fong Erik Wong, John Panagides, Jacques Schipper